Methods of Making and Using Zwitterionic Hydrogel Beads for Protein Therapy and Protein Immobilization

Case ID:
2020-006

BACKGROUND

Proteins are incredibly useful in medicine and industrial chemistry. Many of the most recent breakthroughs in cancer therapy are based on monoclonal antibody treatments. Yet, there are major difficulties that can act as deterrents in developments of such therapies. Similarly, usage of proteins as enzymes is limited by poor stability, short half-life, and difficulties with reusability. With growing usage of proteins as pharmaceuticals and biocatalysts, and apparent shortcomings in both fields, there is a growing need to design materials that are protein compatible and can improve protein stability.

SUMMARY OF TECHNOLOGY

Here a biomimetic strategy inspired by several living organisms is used to maintain protein (enzyme or therapeutic) function by a network of superhydrophilic and osmolyte polymers. Here, zwitterionic microscale hydrogels of two different zwitterionic moieties (carboxybetaine and sulfobetaine), were synthesized, using an inverse emulsion, free radical polymerization reaction technique. Microscale hydrogels were loaded with proteins using a post-fabrication loading technique which prevents unwanted reactions. Protein loading and released from these hydrogels were studied to develop the polymeric network which can increase the protein stability for therapeutic purposes. Furthermore, a reaction scheme was developed and studied for covalent immobilization of protein within the zwitterionic microscale hydrogels. The enzymatic activity of proteins loaded/released, or proteins immobilized within zwitterionic hydrogels were studied.  Our result show increased the conformational stability and half-life of the proteins by using microscale zwitterionic hydrogels. This technology has direct applications for subcutaneous delivery of biologics as well as fabrication of enzyme immobilized materials with extend enzyme lifetime and molecular turnover.

POTENTIAL AREAS OF APPLICATION

  • Biopharmaceuticals: Monoclonal antibody treatments and enzyme therapy
  • Drug delivery: Subcutaneous and pulmonary delivery of biomolecule therapies
  • Enzyme catalyzed processes: In food, pharmaceutical industries and waste treatment 
  • Lab and research materials

MAIN ADVANTAGES

  • Biomimetic approach to increase the protein stability
  • Ability of “post fabrication protein” loading preventing unwanted changes to proteins

STAGE OF DEVELOPMENT

  • Proof-of-concept
Patent Information:
For Information, Contact:
Russell Hopper
Sr. Licensing Associate
Oklahoma State University
russell.hopper@okstate.edu
Inventors:
Joshua Ramsey
Amir Erfani
Nicholas Flynn
Clint Aichele
Keywords:
https://cowboyinnovations-okstate.technologypublisher.com/?q=&hPP=20&idx=Test_Inteum_TechnologyPublisher_okstate_sorted&p=0&hFR%5BTechnology%20Classifications.lvl0%5D%5B0%5D=Research+Tools&is_v=1 ?Test_Inteum_TechnologyPublisher_okstate_sorted%5BhierarchicalMenu%5D%5BTechnology%20Classifications.lvl0%5D%5B0%5D=